Peak Pharmaceuticals, Inc. announced that it will receive $318,500 in funding on April 24, 2023. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -13.46% | -13.46% | +160.12% |
1st Jan change | Capi. | |
---|---|---|
+160.12% | 94.16M | |
+11.75% | 3,129B | |
+10.06% | 86.84B | |
+6.04% | 78.63B | |
-14.66% | 53.93B | |
+26.73% | 48.21B | |
-24.44% | 47.43B | |
+31.74% | 45.58B | |
+82.12% | 41.03B | |
-8.15% | 24.92B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding